Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan Shigeki SatoAzusa TanimotoSeiji Yano Original Article 01 March 2021 Pages: 1009 - 1014
The prevalence of secondary neoplasms in acromegalic patients: possible preventive and/or protective role of metformin Denise CostaFilippo CeccatoPatrizia Gargiulo Original Article Open access 13 March 2021 Pages: 1015 - 1021
Contributions of HOTAIR polymorphisms to the susceptibility of cancer Hu-Nian LiNa DengXi-Wei Ding Original Article 25 February 2021 Pages: 1022 - 1038
Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: Why is it successful or unsuccessful? Tomoya YokotaTetsuro OnitsukaTsuyoshi Onoe Original Article 08 March 2021 Pages: 1039 - 1048
Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting Shin KariyaYasushi ShimizuAkihiro Homma Original Article Open access 08 April 2021 Pages: 1049 - 1056
Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting Manglio Miguel RizzoMaría Virginia BluthgenNicolás Minatta Original Article 14 March 2021 Pages: 1057 - 1064
Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations Yasuhiro KatoGou YamamotoHiroshi Sakai Original Article 03 March 2021 Pages: 1065 - 1072
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis Katsuyuki HottaMakoto NishioKoichi Azuma Original Article Open access 07 April 2021 Pages: 1073 - 1082
Significance of D-dimer-based screening for detecting pre-operative venous thromboembolism in patients with esophageal cancer after neoadjuvant chemotherapy Keita TakahashiMasayuki WatanabeYu Imamura Original Article 01 March 2021 Pages: 1083 - 1090
The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancer Qiaoyan GongJiangfang TianDan Cao Original Article 22 March 2021 Pages: 1091 - 1098
EGFL7 as a novel therapeutic candidate regulates cell invasion and anoikis in colorectal cancer through PI3K/AKT signaling pathway Zhang JuanChu DakeHe Shuixiang Original Article 26 February 2021 Pages: 1099 - 1108
Prognostic value of tumor deposits in locally advanced rectal cancer: a retrospective study with propensity score matching Hang ZhengJixin ZhangXin Wang Original Article 19 March 2021 Pages: 1109 - 1119
Development and external validation of a nomogram for predicting the effect of tumor size on cancer-specific survival of resected gallbladder cancer: a population-based study Yaodong ZhangTao ZhouXiangcheng Li Original Article 05 March 2021 Pages: 1120 - 1129
Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study Ken IshitaniAyako IsoaiNorio Hanafusa Original Article 24 March 2021 Pages: 1130 - 1138
Pelvic reconstruction using an ice-cream cone prosthesis: correlation between the inserted length of the coned stem and surgical outcome Tomohiro FujiwaraJonathan StevensonLee Jeys Original Article 15 March 2021 Pages: 1139 - 1146
Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors Pierre AulogeJulien GarnonAfshin Gangi Original Article 11 March 2021 Pages: 1147 - 1158